Henry O. Gosebruch's Insider Trades & SAST Disclosures
Henry O. Gosebruch's most recent trade in Acelyrin Inc was a trade of 92,158 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on June 7, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Henry O. Gosebruch.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acelyrin Inc | Henry O. Gosebruch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 92,158 | 92,158 | - | - | Director Stock Option (right to buy) | |
| Neumora Therapeutics Inc. | Henry Gosebruch O. | Director, President & CEO | 14 Feb 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | ||
| Neumora Therapeutics Inc. | Gosebruch Henry O. | Director, President & CEO | 14 Feb 2024 | 80,000 | 462,345 | - | 0 | Common Stock | ||
| Acelyrin Inc | Henry O. Gosebruch | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 155,450 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Henry O. Gosebruch | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 155,450 | 155,450 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Henry O. Gosebruch | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 50,000 | 50,000 | - | 18 | 900,000 | Common Stock |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 83,960 | 0 | - | - | Option (Right to Buy) | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 16 May 2022 | 83,960 | 41,623 (0%) | 0% | 155 | 13,013,800 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.86 per share. | 16 May 2022 | 83,960 | 125,583 (0%) | 0% | 54.9 | 4,606,046 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 146.81 per share. | 01 Mar 2022 | 15,733 | 62,767 (0%) | 0% | 146.8 | 2,309,770 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 147.60 per share. | 01 Mar 2022 | 5,167 | 57,600 (0%) | 0% | 147.6 | 762,657 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 148.71 per share. | 01 Mar 2022 | 4,000 | 53,600 (0%) | 0% | 148.7 | 594,824 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 149.38 per share. | 01 Mar 2022 | 100 | 53,500 (0%) | 0% | 149.4 | 14,938 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.54 per share. | 25 Feb 2022 | 30,156 | 56,623 (0%) | 0% | 149.5 | 4,509,528 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 148.62 per share. | 25 Feb 2022 | 8,303 | 42,724 (0%) | 0% | 148.6 | 1,234,012 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 147.54 per share. | 25 Feb 2022 | 5,596 | 51,027 (0%) | 0% | 147.5 | 825,616 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 149.14 per share. | 25 Feb 2022 | 1,101 | 41,623 (0%) | 0% | 149.1 | 164,208 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 36,673 | 55,384 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 30,647 | 30,647 | - | - | Option (right to buy) | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 14,722 | 78,078 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 8,701 | 86,779 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 7,972 | 63,356 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Sep 2021 | 30,000 | 78,500 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Sep 2021 | 30,000 | 18,711 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.74 per share. | 28 Feb 2021 | 22,833 | 48,711 (0%) | 0% | 107.7 | 2,460,027 | Common Stock, $0.01 par value |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 49,068 | 49,068 | - | - | Option(right to buy) | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 22,287 | 42,293 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 14,724 | 71,544 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,972 | 56,820 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 6,555 | 48,848 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 99.49 per share. | 20 Nov 2020 | 33,100 | 20,006 (0%) | 0% | 99.5 | 3,293,119 | Common Stock, $0.01 par shar |
| Abbvie Inc | Henry O. Gosebruch | EVP, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 98.83 per share. | 20 Nov 2020 | 6,900 | 53,106 (0%) | 0% | 98.8 | 681,927 | Common Stock, $0.01 par share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges